Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Celgene
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Eastern Cooperative Oncology Group
Rhizen Pharmaceuticals SA
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
Celgene
Celgene
Celgene
Celgene
Celgene
Celgene
Fondazione Italiana Linfomi - ETS
Northwestern University
Celgene
Takeda
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)